Indication
Subjective Cognitive Decline
3 clinical trials
2 products
Clinical trial
Cholinergic Mechanisms of Attention in AgingStatus: Recruiting, Estimated PCD: 2024-05-30
Product
MecamylamineClinical trial
Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive DeclineStatus: Not yet recruiting, Estimated PCD: 2028-06-30
Clinical trial
Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive DeclineStatus: Recruiting, Estimated PCD: 2026-12-31